As noted in Table 3, high levels of CST4 mRNA were significantly associated with poor prognosis in female, age over 65 years, histologic grade G2 and G3, cancer status as with tumor, residual tumor R0 and R1, radiotherapy, and target therapy in the TCGA. The gene discussed is CST4; the disease is cancer.